Table 1.
Clinical and demographic characteristics of patients included in the study
| Patients included in the study (n=178) | |
|---|---|
| Sociodemographic characteristics | |
| Age in years | 70 (58-77) |
| Sex | |
| Men | 99 (55.6) |
| Women | 79 (44.4) |
| Marital status | |
| Single | 25 (14.0%) |
| Married | 94 (52.8%) |
| Separated or divorced | 11 (6.2%) |
| Widow(er) | 48 (27.0%) |
| Religious affiliation | |
| Yes | 177 (99.4%) |
| No | 1 (0.6%) |
| Clinical variables | |
| LVEF (%) | 32 (25-45) |
| Classification according to the LVEF | |
| HFrEF | 118 (66%) |
| HFmrEF | 29 (16%) |
| HFpEF | 31 (18%) |
| Hospitalizations in the last year | |
| 0 | 1 (0.6%) |
| 1 | 46 (25.8% |
| 2 | 109 (61.2%) |
| >2 | 22 (12.4%) |
| Presence of implantable cardiac device | |
| Yes | 73 (41.0%) |
| No | 105 (59.0%) |
| NYHA functional class | |
| I | 57 (32.0%) |
| II | 86 (48.3%) |
| III | 34 (19.1%) |
| IV | 1 (0.6%) |
| Comorbidities | |
| Atrial fibrillation | 53 (29.8%) |
| Type 2 diabetes mellitus | 56 (31.5%) |
| Chronic kidney disease | 86 (48.3%) |
| Chronic obstructive pulmonary disease | 25 (14.0%) |
| Coronary artery disease | 66 (37.1) |
| Obstructive sleep apnea | 13 (7.3%) |
| Medication | |
| Beta-blockers | 168 (94.4%) |
| ACE inhibitors | 140 (78.7%) |
| ARBs | 134 (75.3%) |
Data presented as amount of patients and (%) for categorical data, or as median and (IQR) for continuous data
LVEF: left ventricular ejection fraction; HFrEF: heart failure with reduced ejection fraction; HFmrEF: heart failure with mildly reduced ejection fraction; HFpEF: heart failure with preserved ejection fraction; ACE: angiotensin-converting-enzyme; ARBs: angiotensin receptor blockers